• -
771 Results
Medical law
Promoted Yet Unproven: How State Laws Expand Access to Unchecked Stem Cell Interventions
The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
Kirstin R.W. Matthews May 13, 2024
electric vehicle factory
How the US-China Trade War and the Inflation Reduction Act Could Shape Mexico’s Nearshoring Future
Amid U.S. efforts to strengthen supply chains and counterbalance China’s growing influence, Mexico is poised to benefit from “nearshoring,” writes scholar Adrian Duhalt. This brief explores how the Inflation Reduction Act and rising trade tensions between the U.S. and China could help Mexico secure its top trading position with the U.S. for years to come.
Adrian Duhalt April 23, 2024
Close up of hands and business giving as illustrated by the exchange of US currency
Do Donor-Advised Funds Need More Regulation?
Donor-advised funds (DAFs) have experienced substantial growth in recent years, prompting debate about abuses of this tax-advantaged vehicle and what policies should be adopted to close loopholes. Fellow Joyce Beebe reviews the design of DAFs, common criticisms, recent policy developments, and opponents’ arguments against additional regulations.
Joyce Beebe April 19, 2024